Yiwen Cheng Selected Research

Yiwen Cheng Research Topics

6	Infections 10/2023 - 12/2014
4	Dysbiosis 01/2022 - 01/2016
4	Inflammation (Inflammations) 01/2022 - 01/2015
2	Neuroinflammatory Diseases 01/2023 - 01/2022
2	Pneumonia (Pneumonitis) 01/2021 - 01/2018
2	Carcinogenesis 01/2020 - 01/2019
2	Diarrhea 01/2018 - 01/2015
1	Non-alcoholic Fatty Liver Disease 05/2024
1	Lung Injury 08/2022
1	Neoplasms (Cancer) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Brucellosis (Malta Fever) 01/2022
1	Photophobia (Light Sensitivity) 01/2022
1	Urinary Tract Infections (Urinary Tract Infection) 01/2017
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2017

3	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2019
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 12/2014
2	Volatile Fatty AcidsIBA 05/2024 - 01/2022
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023 - 01/2022
2	Messenger RNA (mRNA)IBA 06/2022 - 01/2019
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2018
2	Butyrates (Butyrate)IBA 01/2020 - 12/2014
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 01/2015
1	Histones (Histone)IBA 05/2024
1	LipopolysaccharidesIBA 05/2024
1	ChromatinIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 08/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Attenuated VaccinesIBA 01/2022
1	M-cadherinIBA 01/2022
1	Cyclic Nucleotide-Gated Cation ChannelsIBA 01/2022
1	Neuroprotective AgentsIBA 01/2022
1	Agouti Signaling ProteinIBA 01/2022
1	SynucleinsIBA 01/2022
1	Cyclic NucleotidesIBA 01/2022
1	Melanins (Melanin)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Circular RNAIBA 01/2021
1	MutagensIBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Amine Oxidase (Copper-Containing)IBA 01/2018
1	EndotoxinsIBA 01/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2018
1	ChemokinesIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017

4	Therapeutics 01/2022 - 01/2015
1	Immunomodulation 10/2023
1	Intraperitoneal Injections 08/2022
1	Highly Active Antiretroviral Therapy (HAART) 01/2016